Show simple item record

dc.creatorKundaković, Tatjana
dc.creatorKolundžić, Marina
dc.date.accessioned2019-09-02T11:33:47Z
dc.date.available2019-09-02T11:33:47Z
dc.date.issued2013
dc.identifier.issn1568-0266
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1898
dc.description.abstractMetabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called - glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.en
dc.publisherBentham Science Publ Ltd, Sharjah
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173021/RS//
dc.rightsrestrictedAccess
dc.sourceCurrent topics in medicinal chemistry
dc.subjectAntihypertensiveen
dc.subjecthypoglycaemicen
dc.subjecthypolipidemicen
dc.subjectmushroomsen
dc.subjectmetabolic syndromeen
dc.subjectweight lossen
dc.titleTherapeutic Properties of Mushrooms in Managing Adverse Effects in the Metabolic Syndromeen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractКолунджић, Марија; Кундаковић, Татјана;
dc.citation.volume13
dc.citation.issue21
dc.citation.spage2734
dc.citation.epage2744
dc.citation.other13(21): 2734-2744
dc.citation.rankM21
dc.identifier.wos000326986900006
dc.identifier.doi10.2174/15680266113136660196
dc.identifier.pmid24083790
dc.identifier.scopus2-s2.0-84903666946
dc.identifier.rcubconv_2958
dc.type.versionpublishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record